Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland

European Journal of Heart Failure

Volumn 19, Issue 9, 2017, Pages 1095-1104

  Mamas, Mamas A ^a,b,c   Sperrin, Matthew ^c   Watson, Margaret C ^d   Coutts, Alasdair ^e   Wilde, Katie ^e   Burton, Christopher ^f   Kadam, Umesh T ^g   Kwok, Chun Shing ^a,b,e   Clark, Allan B ^h   Murchie, Peter ^e   Buchan, Iain ^c   Hannaford, Philip C ^e   Myint, Phyo K ^e  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d University of Bath   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f NORTHERN GENERAL HOSPITAL   (United Kingdom)

^g KEELE UNIVERSITY   (United Kingdom)

^h UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cancer; Heart failure; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MEDICAL PRACTICE; MORTALITY RATE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SCOTLAND; SEX; SURVIVAL RATE; CLASSIFICATION; EPIDEMIOLOGY; FACTUAL DATABASE; HOSPITALIZATION; MIDDLE AGED; MORTALITY; NEOPLASM; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; SURVIVAL RATE;

EID: 85018792774     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.822     Document Type: Article

References (40)

1. World Health Organization. WHO Global Status Report on Noncommunicable Diseases 2014. 2014. http://www.who.int/nmh/publications/ncd-status-report-2014/en/ (24 March 2016).
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137–1146.
3. Gabet A, Juilliere Y, Lamarche-Vadel A, Vernay M, Olie V. National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000–2012. Eur J Heart Fail 2015;17:583–590.
4. Laribi S, Aouba A, Nikolaou M, Lassus J, Cohen-Solal A, Plaisance P, Pavillion G, Jois P, Fonarow GC, Jougla E, Mebazza A. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail 2012;14:234–239.
5. Stewart S, Ekman I, Ekman T, Oden A, Rosengren A. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes 2010;3:573–580.
6. Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433–443.
7. World Health Organization. Cancer Fact sheet No. 297. 2015. http://www.who.int/mediacentre/factsheets/fs297/en/ (24 March 2017).
8. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunibyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385:977–1010.
9. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315–322.
10. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37–43.
11. Macfarlane TV, Lefevre K, Watson MC. Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer. Br J Cancer 2014;111:1852–1859.
12. Elder R, Kirkpatrick M, Ramsay W, Macleod M, Guthrie B, Sutton M, Watt G. Measuring Quality in Primary Medical Services Using Data from SPICE. NHS National Services Scotland, Edinburgh 2007.
13. National Health Service Primary Care Commissioning. QOF implementation: business rules version 16.0. 2009. http://www.pcc.nhs.uk/145/ (24 March 2017).
14. Information Services Division, NHS National Services Scotland. Measuring long-term conditions in Scotland, June 2008. http://www.isdscotland.org/isd/5658.html (24 March 2017).
15. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515–526.
16. R Core Team. R: a language and environment for statistical computing. 2015. http://www.r-project.org (24 March 2017).
17. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009;119:515–523.
18. Zarrinkoub R, Wettermark B, Wandell P, Mejhert M, Szulkin R, Ljunggren G, Kahan T. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 2013;15:995–1002.
19. Christ M, Stork S, Dorr M, Heppner HJ, Muller C, Wachter R, Riemer U. Heart failure epidemiology 2000–2013: insight from the German Federal Health Monitoring System. Eur J Heart Fail 2016;18:1009–1018.
20. Schmidt M, Ulrichsen SP, Pedersen L, Botker HE, Sorensen HT. Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study. Eur J Heart Fail 2016;18:490–499.
21. Teng TH, Katzenellenbogen JM, Hung J, Knuiman M, Sanfilippo FM, Geelhoed E, Bessarab D, Hobbs M, Thompson SC. A cohort study: temporal trends in prevalence of antecedents, comorbidities and mortality in Aboriginal and non-Aboriginal Australians with first heart failure hospitalization, 2000–2009. Int J Equity Health 2015;14:66.
22. Coles AH, Tisminetzky M, Yarzebski J, Lessard D, Gore JM, Darling CE, Golberg RJ. Magnitude of and prognostic factors associated with 1-year mortality after hospital discharge for acute decompensated heart failure based on ejection fraction findings. J Am Heart Assoc 2015;4:e0002303.
23. Chang PP, Chambless LE, Shahar E, Bertoni AG, Russell SD, Ni H, He M, Mosley TH, Wagenknecht LE, Samadarshi TE, Wruck LM, Rosamond WD. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 2014;113:504–510.
24. James S, Barton D, O'Connell E, Voon V, Murtagh G, Watson C, Murphy T, Prendiville B, Brennan D, Hensey M, O'Neill L, O'Hanlon R, Waterhouse D, Ledwidge M, Gallagher J, McDonald K. Life expectancy for community-based patients with heart failure from time of diagnosis. Int J Cardiol 2015;178:268–274.
25. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R; Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5-year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 2007;28:1128–1134.
26. Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL. Death in heart failure: a community perspective. Circ Heart Fail 2008;1:91–97.
27. Triposkiadis F, Giamouzis G, Parissis J, Starling RC, Boudoulas H, Skoulargis J, Butler J, Filippatos G. Reframing the association and significance of co-morbidities in heart failure. Eur J Heart Fail 2016;18:744–758.
28. Ruiz-Laiglesia FJ, Sanchez-Marteles M, Perez-Calvo JI, Formiga F, Bartolome-Satue JA, Armengou-Arxe A, Lopez-Quiros R, Perez-Silvestre J, Serrado-Iglesias A, Montero-Perez-Barguero M. Comorbidity in heart failure. Results of the Spanish RICA Registry. QJM 2014;107:989–994.
29. Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure-associated hospitalizations in the United States. J Am Coll Cardiol 2013;61:1259–1267.
30. Saczynski JS, Go AS, Magid DJ, Smith DH, McManus DD, Allen L, Ogarek J, Goldberg RJ, Gurwitz JH. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc 2013;61:26–33.
31. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226–1233.
32. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J 1987;8 (Suppl. F):23–26.
33. Kehl KL, Lamont EB, McNeil BJ, Bozeman SR, Kelley MJ, Keating NL. Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer. J Geriatr Oncol 2015;6:202–210.
34. Sarfati D, Gurney J, Stanley J, Salmond C, Crampton P, Dennett E, Koea J, Pearce N. Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. J Clin Epidemiol 2014;67:586–595.
35. Kravchenko J, Berry M, Arbeev K, Kim Lyerly H, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data-based analysis. Lung Cancer 2015;88:85–93.
36. Gandaglia G, Sun M, Popa I, Schiffmann J, Trudeau V, Shariat SF, Trinh QD, Graefen M, Widmer H, Saad F, Briganti A, Montorsi F, Karakiewicz PI. Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study. Clin Genitourin Cancer 2015;13:e123–130.
37. Onwudiwe NC, Kwok Y, Onukwugha E, Sorkin JD, Zuckerman IH, Shaya FT, Daniel Mullins C. Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk. Cancer Med 2014;3:1342–1352.
38. QOF (Quality and Outcomes Framework) database. Data for HF002. https://www.gpcontract.co.uk/child/UK/HF002/15 (24 March 2017).
39. Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort. Am J Cardiol 2014;113:691–696.
40. Meta-Analysis Global Group in Chronic Heart Failure. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012;33:1750–1757.